139 related articles for article (PubMed ID: 11228211)
1. Increased serum FSH in female fragile X premutation carriers with either regular menstrual cycles or on oral contraceptives.
Hundscheid RD; Braat DD; Kiemeney LA; Smits AP; Thomas CM
Hum Reprod; 2001 Mar; 16(3):457-62. PubMed ID: 11228211
[TBL] [Abstract][Full Text] [Related]
2. Evidence of early ovarian aging in fragile X premutation carriers.
Welt CK; Smith PC; Taylor AE
J Clin Endocrinol Metab; 2004 Sep; 89(9):4569-74. PubMed ID: 15356064
[TBL] [Abstract][Full Text] [Related]
3. Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA premutation women.
Murray A; Webb J; MacSwiney F; Shipley EL; Morton NE; Conway GS
Hum Reprod; 1999 May; 14(5):1217-8. PubMed ID: 10325264
[TBL] [Abstract][Full Text] [Related]
4. X chromosome inactivation does not define the development of premature ovarian failure in fragile X premutation carriers.
Spath MA; Nillesen WN; Smits AP; Feuth TB; Braat DD; van Kessel AG; Yntema HG
Am J Med Genet A; 2010 Feb; 152A(2):387-93. PubMed ID: 20101683
[TBL] [Abstract][Full Text] [Related]
5. Imprinting effect in premature ovarian failure confined to paternally inherited fragile X premutations.
Hundscheid RD; Sistermans EA; Thomas CM; Braat DD; Straatman H; Kiemeney LA; Oostra BA; Smits AP
Am J Hum Genet; 2000 Feb; 66(2):413-8. PubMed ID: 10677300
[TBL] [Abstract][Full Text] [Related]
6. Fragile x-associated premature ovarian failure in a large Turkish cohort: Findings of Hacettepe Fragile X Registry.
Utine GE; Şimşek-Kiper PÖ; Akgün-Doğan Ö; Ürel-Demir G; Alanay Y; Aktaş D; Boduroğlu K; Tunçbilek E; Alikaşifoğlu M
Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():76-80. PubMed ID: 29275276
[TBL] [Abstract][Full Text] [Related]
7. The ovarian response in fragile X patients and premutation carriers undergoing IVF-PGD: reappraisal.
Avraham S; Almog B; Reches A; Zakar L; Malcov M; Sokolov A; Alpern S; Azem F
Hum Reprod; 2017 Jul; 32(7):1508-1511. PubMed ID: 28472405
[TBL] [Abstract][Full Text] [Related]
8. Study of FMR1 gene association with ovarian dysfunction in a sample from the Basque Country.
Barasoain M; Barrenetxea G; Huerta I; Télez M; Carrillo A; Pérez C; Criado B; Arrieta I
Gene; 2013 May; 521(1):145-9. PubMed ID: 23537988
[TBL] [Abstract][Full Text] [Related]
9. Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study--preliminary data.
Allingham-Hawkins DJ; Babul-Hirji R; Chitayat D; Holden JJ; Yang KT; Lee C; Hudson R; Gorwill H; Nolin SL; Glicksman A; Jenkins EC; Brown WT; Howard-Peebles PN; Becchi C; Cummings E; Fallon L; Seitz S; Black SH; Vianna-Morgante AM; Costa SS; Otto PA; Mingroni-Netto RC; Murray A; Webb J; Vieri F
Am J Med Genet; 1999 Apr; 83(4):322-5. PubMed ID: 10208170
[TBL] [Abstract][Full Text] [Related]
10. Fragile X premutation in women: recognizing the health challenges beyond primary ovarian insufficiency.
Hoyos LR; Thakur M
J Assist Reprod Genet; 2017 Mar; 34(3):315-323. PubMed ID: 27995424
[TBL] [Abstract][Full Text] [Related]
11. Correlation of FMR4 expression levels to ovarian reserve markers in FMR1 premutation carriers.
Agusti I; Alvarez-Mora MI; Wijngaard R; Borras A; Barcos T; Peralta S; Guimera M; Goday A; Manau D; Rodriguez-Revenga L
J Ovarian Res; 2024 May; 17(1):103. PubMed ID: 38760837
[TBL] [Abstract][Full Text] [Related]
12. Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study.
Rohr J; Allen EG; Charen K; Giles J; He W; Dominguez C; Sherman SL
Hum Reprod; 2008 May; 23(5):1220-5. PubMed ID: 18310677
[TBL] [Abstract][Full Text] [Related]
13. Premature ovarian failure (POF) and fragile X premutation females: from POF to to fragile X carrier identification, from fragile X carrier diagnosis to POF association data.
Uzielli ML; Guarducci S; Lapi E; Cecconi A; Ricci U; Ricotti G; Biondi C; Scarselli B; Vieri F; Scarnato P; Gori F; Sereni A
Am J Med Genet; 1999 May; 84(3):300-3. PubMed ID: 10331612
[TBL] [Abstract][Full Text] [Related]
14. Menstrual disorders and endocrine profiles in fragile X carriers prior to 40 years of age: a pilot study.
Braat DD; Smits AP; Thomas CM
Am J Med Genet; 1999 Apr; 83(4):327-8. PubMed ID: 10208172
[TBL] [Abstract][Full Text] [Related]
15. Reproductive and menstrual history of females with fragile X expansions.
Murray A; Ennis S; MacSwiney F; Webb J; Morton NE
Eur J Hum Genet; 2000 Apr; 8(4):247-52. PubMed ID: 10854106
[TBL] [Abstract][Full Text] [Related]
16. FSHB -211 G>T is a major genetic modulator of reproductive physiology and health in childbearing age women.
Rull K; Grigorova M; Ehrenberg A; Vaas P; Sekavin A; Nõmmemees D; Adler M; Hanson E; Juhanson P; Laan M
Hum Reprod; 2018 May; 33(5):954-966. PubMed ID: 29617818
[TBL] [Abstract][Full Text] [Related]
17. Premature ovarian failure and fragile X premutation: a study on 45 women.
Bussani C; Papi L; Sestini R; Baldinotti F; Bucciantini S; Bruni V; Scarselli G
Eur J Obstet Gynecol Reprod Biol; 2004 Feb; 112(2):189-91. PubMed ID: 14746957
[TBL] [Abstract][Full Text] [Related]
18. Fragile X premutation in women with sporadic premature ovarian failure in Slovenia.
Gersak K; Meden-Vrtovec H; Peterlin B
Hum Reprod; 2003 Aug; 18(8):1637-40. PubMed ID: 12871874
[TBL] [Abstract][Full Text] [Related]
19. Premature ovarian failure in the fragile X syndrome.
Sherman SL
Am J Med Genet; 2000; 97(3):189-94. PubMed ID: 11449487
[TBL] [Abstract][Full Text] [Related]
20. Association between idiopathic premature ovarian failure and fragile X premutation.
Marozzi A; Vegetti W; Manfredini E; Tibiletti MG; Testa G; Crosignani PG; Ginelli E; Meneveri R; Dalprà L
Hum Reprod; 2000 Jan; 15(1):197-202. PubMed ID: 10611212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
